Release Date: 31/12/21 09:55 Summary: Becoming a substantial holder for GL1 Price Sensitive: No Download Document 376.64KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%